Global Cosmetic Surgery Market Size, Share, Opportunities, And Trends By Type (Surgical Procedures, Non-Surgical Procedures, Liposuction), By Body Part (Face And Head, Breast, Body And Extremities), And By Geography - Forecasts From 2024 To 2029

The cosmetic surgery market is anticipated to increase from US$48.24 billion in 2022 to US$89.671 billion in 2029 at a CAGR of 9.26%.

Cosmetic surgery is a type of medical operation that uses both surgical and non-surgical methods to improve looks. Cosmetic surgery, also known as aesthetic surgery, is a branch of plastic surgery that aims to enhance a person's appearance through surgical and medical techniques. It is elective and focuses on improving aesthetic appeal, symmetry, and proportion. There are various types of cosmetic surgery, including facial procedures, body contouring, breast procedures, and skin rejuvenation. Reasons for cosmetic surgery include enhancement, correction, and aging reversal. A person may have cosmetic surgery done to reduce, accentuate, lift, or enhance a physical portion. Over the years, the demand for cosmetic surgery has grown significantly, spurred by improvements in surgical techniques, rising affluence, accelerating urbanization, the cultural effects of globalization, and an increase in doctors with specialized training.

MARKET DRIVERS:

• An increase in licensed medical spas to draw clientele for cosmetic procedures is anticipated in the growth of the market.

An expansive and appealing aesthetic medicine industry is now operating worldwide because of the rise in the number of patients undergoing surgical and non-surgical cosmetic procedures. The number of medical spas that have FDA approval and licensing has greatly expanded as a result of this factor in many various countries. Intense pricing competition brought on by the proliferation of medical spas offering a wide range of services has driven down the price of cosmetic procedures even more.

• Technology-advanced product accessibility is expected to drive the demand for cosmetic procedures globally

Leading producers of goods and devices on the market noted the profitable expansion and are working to enhance their current market share. Due to the growing demand for advanced products with fewer side effects and post-surgical interventions, market players are focusing on R&D to introduce advanced products.

By Geography

Geographically, the cosmetic surgery market is segmented as North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The biggest market for cosmetic surgery is in the United States, followed by Europe. Asia Pacific is also anticipated to have the fastest regional market growth. The availability of skilled surgeons, rising healthcare costs, increased technology spillover from developed economies, and expanding awareness of surgery are all factors contributing to this growth.

Key Developments:

• February 2023: Candela announced the launch of the FDA-cleared Profound Matrix System, designed to correct, maintain, and restore skin at different stages of aging. The system includes the Sublime, Sublative RF, and Matrix Pro applicators. The Sublime and Sublative RF treatments improve fine line and wrinkle appearance, while the Matrix Pro applicator regenerates and builds collagen, enhancing overall skin appearance and texture.
• June 2022: Sinclair, a London-based global aesthetics company, has announced a significant rebranding. The company has added complementary medicines to its already exceptional range of injectables, including MaiLi's latest HA technology and Lanluma, an injectable collagen stimulant. The new EBD business offers a range of energy-based solutions. Sinclair's growing portfolio, educational programs through Sinclair College, and global presence reflect its new identity. The brand has transformed into contemporary, lively, and premium while maintaining its elegance.
• March 2022: Sientra, a silicone gel breast implant manufacturer, has been approved by Health Canada for the first time in 20 years. The High-Strength Cohesive Silicone Gel Breast Implants, distributed by Clarion Medical Technologies, are backed by clinical data and have an unrivaled safety profile. Sientra is the only brand of breast implants in Canada available exclusively from board-certified plastic surgeons. The company will offer implants in Canada through local partner Kai Aesthetic, ensuring high quality, safety, and service standards.

Product Offerings:

• truSculpt® flex: Cutera's truSculpt® flex is based on the original Multi-Directional Stimulation (MDS), a brand-new technique for direct muscle stimulation that offers secure and reliable outcomes. MDS employs a bioelectrical impulse that has been shown via studies to give targeted muscle stimulation for the best thigh, glute, and abdominal strengthening, firming and toning results. The abdomen, buttocks, and thigh regions of truSculpt flex are simultaneously stimulated by eight different muscle groups. More treatment space is covered by truSculpt flex than by any other body sculpting device. The exercise plans include interval training, strength training, and a conditioning routine. The truSculpt flex workout is much more intense than standard gym-based activities.
• The Lumenis M22TM Modular Aesthetic Laser Multi-Application Platform: A modular multi-application platform called M22TM is used to treat and remove hair from more than 30 different skin diseases. M22TM, which is used by doctors all over the world, enables one to effectively treat a wide range of patients and conditions. It can combine four different technologies in a Modular System. With the M22TM Universal IPL and AOPT combined, advanced users have complete control and can easily customize the parameters for each patient and each condition. Lumenis also has a premium M22 version with the golden line design that offers the aesthetic medical sector precise, secure, and successful light and laser-based therapies.

Global Cosmetic Surgery Market Scope:

 

Report Metric	Details
Market Size Value in 2022	US$48.24 billion
Market Size Value in 2029	US$89.671 billion
Growth Rate	CAGR of 9.26% from 2022 to 2029
Base Year	2022
Forecast Period	2024 – 2029
Forecast Unit (Value)	USD Billion
Segments Covered	Type Body Part Geography
Companies Covered	Candela Corporation Allergan Merz Pharma Mentor Worldwide LLC Lumenis Sinclair Pharma Cutera
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Customization Scope	Free report customization with purchase

 

Segmentation

• By Type
  • Surgical Procedures
  • Non-Surgical Procedures
  • Liposuction
• By Body Part
  • Face and Head
  • Breast
  • Body and Extremities
• By Geography
  • North America
    • USA
    • Mexico
    • Canada
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Taiwan
    • Thailand
    • Indonesia
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

1.8. Key Benefits to the stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

3.2. CXO Perspective

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. GLOBAL COSMETIC SURGERY MARKET, BY TYPE

5.1. Introduction

5.2. Surgical Procedures

5.2.1. Market Opportunities and Trends

5.2.2. Growth Prospects

5.2.3. Geographic Lucrativeness

5.3. Non-Surgical Procedures

5.3.1. Market Opportunities and Trends

5.3.2. Growth Prospects

5.3.3. Geographic Lucrativeness

5.4. Liposuction

5.4.1. Market Opportunities and Trends

5.4.2. Growth Prospects

5.4.3. Geographic Lucrativeness

6. GLOBAL COSMETIC SURGERY MARKET, BY BODY PART

6.1. Introduction

6.2. Face and Breast

6.2.1. Market Opportunities and Trends

6.2.2. Growth Prospects

6.2.3. Geographic Lucrativeness

6.3. Breast

6.3.1. Market Opportunities and Trends

6.3.2. Growth Prospects

6.3.3. Geographic Lucrativeness

6.4. Body and Extremities

6.4.1. Market Opportunities and Trends

6.4.2. Growth Prospects

Geographic Lucrativeness

7. GLOBAL COSMETIC SURGERY MARKET, BY GEOGRAPHY

7.1. Introduction

7.2. North America

7.2.1. By Type

7.2.2. By Body Part

7.2.3. By Country

7.2.3.1. United States

7.2.3.1.1. Market Opportunities and Trends

7.2.3.1.2. Growth Prospects

7.2.3.2. Canada

7.2.3.2.1. Market Opportunities and Trends

7.2.3.2.2. Growth Prospects

7.2.3.3. Mexico

7.2.3.3.1. Market Opportunities and Trends

7.2.3.3.2. Growth Prospects

7.3. South America

7.3.1. By Type

7.3.2. By Body Part

7.3.3. By Country 

7.3.3.1. Brazil

7.3.3.1.1. Market Opportunities and Trends

7.3.3.1.2. Growth Prospects

7.3.3.2. Argentina

7.3.3.2.1. Market Opportunities and Trends

7.3.3.2.2. Growth Prospects

7.3.3.3. Others

7.3.3.3.1. Market Opportunities and Trends

7.3.3.3.2. Growth Prospects

7.4. Europe

7.4.1. By Type

7.4.2. By Body Part

7.4.3. By Country

7.4.3.1. United Kingdom

7.4.3.1.1. Market Opportunities and Trends

7.4.3.1.2. Growth Prospects

7.4.3.2. Germany

7.4.3.2.1. Market Opportunities and Trends

7.4.3.2.2. Growth Prospects

7.4.3.3. France

7.4.3.3.1. Market Opportunities and Trends

7.4.3.3.2. Growth Prospects

7.4.3.4. Italy

7.4.3.4.1. Market Opportunities and Trends

7.4.3.4.2. Growth Prospects

7.4.3.5. Spain

7.4.3.5.1. Market Opportunities and Trends

7.4.3.5.2. Growth Prospects

7.4.3.6. Others

7.4.3.6.1. Market Opportunities and Trends

7.4.3.6.2. Growth Prospects

7.5. Middle East and Africa

7.5.1. By Type

7.5.2. By Body Part

7.5.3. By Country

7.5.3.1. Saudi Arabia

7.5.3.1.1. Market Opportunities and Trends

7.5.3.1.2. Growth Prospects

7.5.3.2. UAE

7.5.3.2.1. Market Opportunities and Trends

7.5.3.2.2. Growth Prospects

7.5.3.3. Others

7.5.3.3.1. Market Opportunities and Trends

7.5.3.3.2. Growth Prospects

7.6. Asia Pacific

7.6.1. By Type

7.6.2. By Body Part

7.6.3. By Country

7.6.3.1. Japan

7.6.3.1.1. Market Opportunities and Trends

7.6.3.1.2. Growth Prospects

7.6.3.2. China

7.6.3.2.1. Market Opportunities and Trends

7.6.3.2.2. Growth Prospects

7.6.3.3. India

7.6.3.3.1. Market Opportunities and Trends

7.6.3.3.2. Growth Prospects

7.6.3.4. South Korea

7.6.3.4.1. Market Opportunities and Trends

7.6.3.4.2. Growth Prospects

7.6.3.5. Taiwan

7.6.3.5.1. Market Opportunities and Trends

7.6.3.5.2. Growth Prospects

7.6.3.6. Thailand

7.6.3.6.1. Market Opportunities and Trends

7.6.3.6.2. Growth Prospects

7.6.3.7. Indonesia

7.6.3.7.1. Market Opportunities and Trends

7.6.3.7.2. Growth Prospects

7.6.3.8. Others

7.6.3.8.1. Market Opportunities and Trends

7.6.3.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. Candela Corporation

9.2. Allergan

9.3. Merz Pharma

9.4. Mentor Worldwide LLC

9.5. Lumenis

9.6. Sinclair Pharma

9.7. Cutera

Candela Corporation

Allergan

Merz Pharma

Mentor Worldwide LLC

Lumenis

Sinclair Pharma

Cutera